Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • brokenideas brokenideas Oct 19, 2012 7:20 PM Flag

    Potential Monday headline....

    A key problem for Vertex is that its management doesn't have much credibility on WS. They released three times data on the CF combo study, and each time it has been misleading or unclear. So, rational investors, think that there is potential in the CF franchise but also are not certain about Vertex ability to execute the trials or understand the data. It is annoying for the investors that are long in the stock because even when in the long run the company may do well, the stock bounces in ways that are crazy ... I wish one day they can find new management that knows how to talk to WS ...

    In addition to that, each time they released earnings they missed the estimates, they have been unable to even understand/predict the revenue of the HCV drug ... each time they have to change estimates to lower revenues ... that is not nice from the investors perspective.

 
VRTX
88.42+4.00(+4.74%)May 24 4:00 PMEDT